Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001130319-03-000711
Filing Date
2003-09-15
Accepted
2003-09-15 12:46:40
Documents
2
Period of Report
2003-09-15

Document Format Files

Seq Description Document Type Size
1 FORM 6-K o10724e6vk.htm 6-K 17280
3 GRAPHIC o10724o1072401.gif GRAPHIC 3108
  Complete submission text file 0001130319-03-000711.txt   21894
Mailing Address
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 03895203
SIC: 2834 Pharmaceutical Preparations